US Patent 7279582 Retroviral protease inhibiting compounds
Patent 7279582 was granted and assigned to Abbott on October, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+41 characters)
Article
Patent abstract
A compound of the formula:
Edits on 4 Aug, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
72795820
Date of Patent
October 9, 2007
0Patent Application Number
102806520
Date Filed
October 25, 2002
0Patent Primary Examiner
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07279582 Retroviral protease inhibiting compounds US Patent 7279582 Retroviral protease inhibiting compounds
Infobox
Patent Number
0727958200
Patent Number
727958200
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072795820
Date of Patent
October 9, 2007
0Patent Application Number
102806520
Date Filed
October 25, 2002
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072795820
Date of Patent
October 9, 2007
0Patent Application Number
102806520
Date Filed
October 25, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07279582 Retroviral protease inhibiting compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07279582
Date of patent
October 9, 2007
Patent application number
10280652
Date Filed
October 25, 2002
Patent primary examiner
Find more entities like US Patent 7279582 Retroviral protease inhibiting compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
